SCHEMBL9342

SCHEMBL9342

CC(C)(C)C[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6989643 0.96
SCHEMBL20141641 0.96
SCHEMBL20141352 0.96
SCHEMBL664039 0.77
SCHEMBL1031834 0.72
SCHEMBL293898 0.72
SCHEMBL16872607 0.72
SCHEMBL11372052 0.72
SCHEMBL41539 0.72
SCHEMBL1498735 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8184 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115448924-B Use of nucleoside analogues or combination formulations containing nucleoside analogues in antiviral therapy 中国科学院上海药物研究所 2024-06-18 CN claimed
CN-114014878-B Conjugated alkenyl zinc reagent, preparation method and application thereof 南开大学 2024-06-07 CN claimed
CN-118159542-A Substituted 2, 3-dihydro [1,3] thiazolo [4,5-b ] pyridines, salts thereof and their use as herbicidal agents 拜耳公司 2024-06-07 CN claimed
CN-116535439-B Cyclopropane skeleton monophosphine ligand and palladium complex thereof, and preparation method and application thereof 南开大学 2024-05-28 CN claimed
CN-114423742-B Benzotriazole-based compound, light absorber and resin composition 三井化学株式会社 2024-05-28 CN claimed
US-11919923-B2 Antiviral application of nucleoside analog or combination formulation containing nucleoside analog SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2024-03-05 US claimed
WO-2024027844-A1 PHARMACEUTICAL COMPOSITION AND USE THEREOF 临港国家实验室 2024-02-08 WO claimed
CN-117503776-A Pharmaceutical composition and application thereof 临港国家实验室 2024-02-06 CN claimed
WO-2024002112-A1 METHOD FOR TREATING FELINE CORONAVIRUS OR CALICIVIRUS INFECTION 苏州旺山旺水生物医药股份有限公司 2024-01-04 WO claimed
US-11844846-B2 Styrylbenzothiazole derivatives and uses in imaging methods EMORY UNIVERSITY (US) 2023-12-19 US claimed
US-4829070-A PRODRUG FOR SUSTAINED RELEASE OF DOPAMINE UNIVERSITY OF FLORIDA (US) 1989-05-09 US claimed
EP-0275101-A2 Novel peptidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1988-07-20 EP claimed
US-4727079-A Brain-specific dopaminergic activity involving dihydropyridine carboxamides, dihydroquinoline and isoquinoline carboxamides UNIVERSITY OF FLORIDA (US) 1988-02-23 US claimed
EP-0104964-B1 PEPTIDE DERIVATIVES AS INHIBITORS OF ACID PROTEASES SANOFI S.A. (FR) 1987-07-01 EP claimed
EP-0189203-A2 Peptidylaminodiols ABBOTT LABORATORIES (US) 1986-07-30 EP claimed
US-4549992-A Antihypertensive amides USV PHARMACEUTICAL CORP. (US) 1985-10-29 US claimed
US-4481192-A HYPOTENSIVE, ANTIULCER SANOFI (FR) 1984-11-06 US claimed
EP-0104964-A1 Peptide derivatives as inhibitors of acid proteases SANOFI S.A. (FR) 1984-04-04 EP claimed
EP-0000809-B1 ANTI-INFLAMMATORY 1-PHENYLETHANOLAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THEREOF AND PROCESSES FOR THEIR MANUFACTURE IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-04-14 EP claimed
EP-0000809-A1 Anti-inflammatory 1-phenylethanolamine derivatives, pharmaceutical compositions thereof and processes for their manufacture IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1979-02-21 EP claimed